Concentrix (NASDAQ:CNXC – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $2.95 EPS for the quarter, topping the consensus estimate of $2.93 by $0.02, Briefing.com reports. The company had revenue of $2.55 billion during the quarter, compared to analyst estimates of $2.54 billion. Concentrix had a net margin of 3.25% and a return on equity of 16.02%. The firm’s revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.26 EPS. Concentrix updated its Q1 2026 guidance to 2.570-2.690 EPS and its FY 2026 guidance to 11.480-12.070 EPS.
Concentrix Stock Down 8.1%
NASDAQ CNXC opened at $40.48 on Tuesday. The business’s fifty day simple moving average is $38.43 and its 200-day simple moving average is $46.77. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 1.10. The firm has a market cap of $2.52 billion, a PE ratio of 8.56, a P/E/G ratio of 0.59 and a beta of 0.48. Concentrix has a 52 week low of $31.63 and a 52 week high of $66.00.
Insider Activity
In other news, CEO Christopher A. Caldwell acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, October 31st. The stock was purchased at an average cost of $40.00 per share, for a total transaction of $40,000.00. Following the completion of the transaction, the chief executive officer owned 287,661 shares in the company, valued at approximately $11,506,440. This trade represents a 0.35% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 3.20% of the company’s stock.
Hedge Funds Weigh In On Concentrix
Analysts Set New Price Targets
A number of analysts have recently commented on CNXC shares. Wall Street Zen raised shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, October 25th. Barrington Research reiterated an “outperform” rating and set a $62.00 price objective on shares of Concentrix in a research note on Monday. Robert W. Baird reduced their target price on Concentrix from $75.00 to $62.00 and set an “outperform” rating for the company in a report on Monday, September 29th. Weiss Ratings upgraded Concentrix from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and issued a $80.00 price target on shares of Concentrix in a research note on Tuesday, September 23rd. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, Concentrix currently has a consensus rating of “Moderate Buy” and an average target price of $66.25.
Read Our Latest Research Report on CNXC
Key Concentrix News
Here are the key news stories impacting Concentrix this week:
- Positive Sentiment: Barrington Research reaffirmed an “outperform” rating and set a $62.00 price target, signaling analyst conviction that shares have upside from current levels. Read More.
- Neutral Sentiment: Concentrix reported fiscal Q4 and full-year 2025 results; the release is driving today’s market action as investors parse revenue, margins and management commentary for forward guidance. Read More.
- Neutral Sentiment: Pre-earnings previews and valuation looks have been published, giving investors context on expectations and multiples ahead of the print; these pieces discuss whether recent share moves and valuation are warranted. Read More.
- Neutral Sentiment: Coverage pieces and earnings previews outline key items to watch (revenue growth, margin trends, contract mix and guidance), which can amplify volatility as the market digests results. Read More.
- Neutral Sentiment: Reported short-interest data in the feed is anomalous (shows zero shares), so it does not appear to be a meaningful driver of today’s move based on the available figures.
- Negative Sentiment: Analysts and articles flag concern that while Concentrix has previously beaten guidance, expected revenue growth is slowing — investors often punish stocks when earnings beats are accompanied by weaker growth outlooks. Read More.
- Negative Sentiment: Commentary questioning whether current pricing reflects Concentrix’s multi?year share decline and changing fundamentals may reinforce selling pressure until there’s clearer guidance or an earnings rebound. Read More.
About Concentrix
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology?driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back?office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Read More
- Five stocks we like better than Concentrix
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
